Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial fission regulator 1 (MTFR1) is a poly-proline-rich protein localized to the mitochondria, where it regulates mitochondrial fission and fusion processes integral to cellular energy production, morphology, and stress response[2][3][4][5][13]. The protein is evolutionarily conserved and related to chondrocyte function in certain species. MTFR1 is overexpressed in several cancers, promoting tumor cell proliferation, survival under metabolic stress, and resistance to chemotherapy[2][9]. Its activity is regulated post-translationally, such as via NEK1-mediated phosphorylation, which shifts mitochondrial dynamics toward fusion in response to stress[2]. Given its central role in mitochondrial organization and cellular adaptation, MTFR1 is implicated both as a therapeutic target and a biomarker in oncology and disorders related to mitochondrial dysfunction[2][9][13].
Drugs targeting MTFR1 may modulate mitochondrial fusion/fission balance and affect cell proliferation, survival, and drug resistance in cancer cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial fission regulator 1 (MTFR1).